Close Menu

NEW YORK (GenomeWeb) – Yourgene Health – formerly known as Premaitha Health – today reported a 45 percent increase in revenues for the first half of fiscal year 2018.

For the six months ended Sept. 30, the Manchester, UK-based noninvasive prenatal testing company reported £3.9 million ($5.0 million) in revenues compared to £2.7 million during the prior-year period. Revenues consisted of £2.5 million from products and £1.4 million from services.

Testing volumes during H1 increased 73 percent to 38,000 from 22,000 in H1 of FY2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.